Single-Step Nanoplasmonic VEGF165Aptasensor for Early Cancer Diagnosis-Reference-Cited by-同舟云学术

Single-Step Nanoplasmonic VEGF165Aptasensor for Early Cancer Diagnosis

Published:2012-08-21 Issue:9 Volume:6 Page:7607-7614
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Cho Hansang¹²,Yeh Erh-Chia¹,Sinha Raghu³,Laurence Ted A.²,Bearinger Jane P.²,Lee Luke P.¹

Affiliation:

1. Berkeley Sensor and Actuator Center, Department of Bioengineering, Department of Electrical Engineering and Computer Science, University of California, Berkeley, California 94720, United States

2. Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States

3. Penn State Hershey Cancer Institute, Department of Biochemistry and Molecular Biology, Pennsylvania State College of Medicine, Hershey, Pennsylvania 17033, United States

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn203833d

Reference58 articles.

1. The case for early detection

2. Protein biomarker discovery and validation: the long and uncertain path to clinical utility

3. T cell epitope–specific immune therapy for rheumatic diseases

4. Array-Based Electrical Detection of DNA with Nanoparticle Probes

5. In vitro selection of RNA molecules that bind specific ligands

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-droplet multiplex immunoassays for hypoxia-induced single-cell cytokines;Talanta;2024-10

2. Computational Frontiers in Aptamer-Based Nanomedicine for Precision Therapeutics: A Comprehensive Review;ACS Omega;2024-06-10

3. Gold nanostructure-enhanced immunosensing: ultra-sensitive detection of VEGF tumor marker for early disease diagnosis;Scientific Reports;2024-05-07

4. Gold Nanostructure-Enhanced Immunosensing: Ultra-Sensitive Detection of VEGF Tumor Marker for Early Disease Diagnosis;2024-01-29

5. Aptamer-based Theranostics in Oncology: Design Strategies and Limitations;BIO Integration;2024